“Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.”, Ophthalmic Epidemiol, vol. 20, no. 2, pp. 109-13, 2013.
, “Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.”, Ophthalmic Epidemiol, vol. 17, no. 1, pp. 66-73, 2010.
, “National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10.”, Arch Ophthalmol, vol. 121, no. 2, pp. 211-7, 2003.
, “The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.”, Invest Ophthalmol Vis Sci, vol. 49, no. 10, pp. 4340-6, 2008.
, “Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.”, Ophthalmology, vol. 112, no. 4, pp. 533-9, 2005.
, “Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16.”, Arch Ophthalmol, vol. 124, no. 4, pp. 537-43, 2006.
,